Exploring PPAR Gamma and PPAR Alpha's Regulation Role in Metabolism via Epigenetics Mechanism

被引:1
|
作者
Malodobra-Mazur, Malgorzata [1 ]
Oldakowska, Monika [1 ]
Dobosz, Tadeusz [1 ]
机构
[1] Wroclaw Med Univ, Dept Forens Sci, Div Mol Tech, Sklodowskiej Curie 52, PL-51367 Wroclaw, Poland
关键词
PPARA; PPARG; metabolic syndrome; obesity; DNA methylation; histone modifications; ACTIVATED-RECEPTOR-GAMMA; DNA METHYLATION; INSULIN-RESISTANCE; LIVER; INFLAMMATION; ADIPOCYTES; FAT; ADIPOGENESIS; SENSITIVITY; FIBROSIS;
D O I
10.3390/biom14111445
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) belong to a family of nuclear receptors. To date, three types of PPARs, namely PPAR alpha, PPAR delta, and PPAR gamma, have been identified, demonstrating co-expression across numerous tissues. PPAR gamma is primarily distributed in adipose tissue, the colon, the immune system, and the retina, while PPAR alpha is predominantly expressed in metabolic tissues such as brown adipose tissue, the liver, and the kidneys. Both PPAR gamma and PPAR alpha play crucial roles in various cellular processes. Recent data suggest that the PPAR family, among other mechanisms, might also be regulated by epigenetic mechanisms. Our recent studies, alongside numerous others, have highlighted the pivotal roles of DNA methylation and histone modifications in the regulation of PPAR gamma and PPAR alpha, implicating them in the deterioration of metabolic disorders via epigenetic mechanisms. This still not fully understood mechanism of regulation in the nuclear receptors family has been summarized and described in the present paper. The present review summarizes the available data on PPAR gamma and PPAR alpha regulation via epigenetic mechanisms, elucidating the link between the development of metabolic disorders and the dysregulation of PPAR gamma and PPAR alpha resulting from these mechanisms.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Role of PPARα in the regulation of glutathione metabolism
    Guelzim, Najoua
    Huneau, Jean-Francois
    Tome, Daniel
    Hermier, Dominique
    FASEB JOURNAL, 2010, 24
  • [2] Regulation of Ketone Body Metabolism and the Role of PPARα
    Grabacka, Maja
    Pierzchalska, Malgorzata
    Dean, Matthew
    Reiss, Krzysztof
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12):
  • [3] The role of PPAR-alpha and PPAR-gamma in obesity-induced hepatic inflammation
    Stienstra, R.
    Duval, C.
    Kersten, S.
    Muller, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S278 - S278
  • [4] Peroxisome Proliferator Activated Receptor-Alpha (PPARα) and PPAR Gamma Coactivator-1alpha (PGC-1α) Regulation of Cardiac Metabolism in Diabetes
    Duncan, Jennifer G.
    PEDIATRIC CARDIOLOGY, 2011, 32 (03) : 323 - 328
  • [5] Peroxisome Proliferator Activated Receptor-Alpha (PPARα) and PPAR Gamma Coactivator-1alpha (PGC-1α) Regulation of Cardiac Metabolism in Diabetes
    Jennifer G. Duncan
    Pediatric Cardiology, 2011, 32 : 323 - 328
  • [6] Lipotoxic dilated cardiomyopathy in mice is exacerbated by a PPAR alpha agonist, but not by a dual agonist of PPAR alpha and PPAR gamma
    Vikramadithyan, RK
    Hirata, K
    Yagyu, H
    Hu, YY
    Homma, S
    Goldberg, IJ
    CIRCULATION, 2003, 108 (17) : 13 - 14
  • [7] Role of PPAR in the pharmacological regulation of lipoprotein metabolism by fibrates and thiazolidinediones
    Staels, B
    Auwerx, J
    CURRENT PHARMACEUTICAL DESIGN, 1997, 3 (01) : 1 - 14
  • [8] A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis
    Najoua Guelzim
    François Mariotti
    Pascal G. P. Martin
    Frédéric Lasserre
    Thierry Pineau
    Dominique Hermier
    Amino Acids, 2011, 41 : 969 - 979
  • [9] A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis
    Guelzim, Najoua
    Mariotti, Francois
    Martin, Pascal G. P.
    Lasserre, Frederic
    Pineau, Thierry
    Hermier, Dominique
    AMINO ACIDS, 2011, 41 (04) : 969 - 979
  • [10] Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists
    Cooper, ME
    Forbes, JM
    Smith, CM
    Lassila, M
    Jandeleit-Dahm, KA
    Allen, TJ
    Calkin, AC
    DIABETOLOGIA, 2005, 48 : A403 - A404